WHY ENROLL IN THIS NEUROGENIC OH CLINICAL TRIAL?

Clinical trials are a part of research and are at the heart of all medical advances. Although droxidopa has been approved by the FDA, more information about the long term effectiveness of this treatment is required by the FDA. By participating in this clinical trial you will play an important role in the discovery of additional information about this medication, which will be helpful to the treatment of patients with symptomatic neurogenic OH in the future.